Evidence that deficient IFN-γ production is a biological basis of herpes simplex virus type-2 neurovirulence

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 66-75

  Lewandowski, Gail ^a   Hobbs, Monte ^b   Geller, Alfred ^c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Brain; Gene therapy; Immunosuppression; Neural immune; Neuropathogenesis

Indexed keywords

GAMMA INTERFERON;

ANIMAL EXPERIMENT; ARTICLE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 2; HOST RESISTANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFECTION RESISTANCE; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; VIRUS INFECTIVITY;

EID: 0031837736     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00160-4     Document Type: Article

References (33)

1. Bouley D.M., Kanangat S., Wire W., Rouse B.T. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J. Immunol. 155:1995;3964-3971.
2. Brandt C.R., Grau D.R. Mixed infection with herpes simplex virus type 1 generates recombinants with increased ocular and neurovirulence. Invest. Ophthalmol. Vis. Sci. 31(11):1990;2214-2223.
3. Chen S.-H., Oakes J.E., Lausch R.N. Synergistic anti-herpes effect of TNF-alpha and IFN-gamma in human corneal epithelial cells compared with that in corneal fibroblasts. Antiviral Res. 25:1994;201-213.
4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
5. Deschl U., Stitz L., Herzog S., Frese K., Rott R. Determination of immune cells and expression of major histocompatibility complex class II antigen in encephalitic lesions of experimental Borna disease. Acta Neuropathol. 81:1990;41-50.
6. Feduchi E., Alonso M.A., Carrasco L. Human gamma interferon and tumor necrosis factor exert a synergistic blockade on the replication of herpes simplex virus. J. Virol. 63:1989;1354-1359.
7. Feduchi E., Carrasco L. Mechanism of inhibition of HSV-1 replication by tumor necrosis factor and interferon-gamma. Virol. 180:1991;822-825.
8. Geiger K.D., Gurushanthaiah D., Howes E.L., Lewandowski G.A., Reed J.C., Bloom F.E., Sarvetnick N.E. Cytokine-mediated survival from lethal herpes simplex virus infection: Role of programmed neuronal death. Proc. Natl. Acad. Sci. USA. 92:1995;3411-3415.
9. Geller A.I., Breakefield X.O. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science. 241:1988;1667-1669.
10. Geller A.I., During M.J., Haycock J.W., Freese A., Neve R. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a herpes simplex virus type 1 vector. PNAS. 90:1993;7603-7607.
11. Gresser I., Tovey M.G., Maury C., Bandu M.-T. Role of interferon in the pathogenesis of virus disease in mice as demonstrated by the use of anti-interferon serum. J. Exp. Med. 144:1976;1316-1323.
12. Ho D.Y. Amplicon-based herpes simplex virus vectors. Methods in Cell Biol. 43:1994;191-210.
13. Hobbs M., Weigle W.O., Noonan D.J., Torbett B.R., McEvilly R.J., Koch R.J., Cardenas G.J., Ernst D.N. Pattern of cytokine gene expression by CD4+ T cells from young and old mice. J. Immunol. 150:1993;3602-3614.
14. Joly E., Oldstone M.B.A. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science. 253(5025):1991;1283-1285.
15. Kumano Y., Yamamoto M., Mori R. Protection against herpes simplex virus infection in mice by recombinant murine interferon-beta in combination with antibody. Antiviral Res. 7:1987;289-301.
16. Lewandowski, G., 1997. Immunohistochemical examination of intracerebral T cell recruitment and adhesion molecule induction in herpes simplex virus-infected mice. Brain, Behavior, Immun., in press.
17. Lewandowski G., Hobbs M.V. Evidence for deficiencies in intracerebral cytokine production, adhesion molecule induction, and T cell recruitment in herpes simplex virus type-2 infected mice. J. Neuroimmunol. 61:1997;58-65.
18. Lewandowski G., Hobbs M.V., Bloom F.E. Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2. J. Neuroimmunol. 55:1994;23-34.
19. Lewandowski G.A., Lo D., Bloom F.E. Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: A possible mechanism of evasion of the immune response. Proc. Natl. Acad. Sci. USA. 90:1993;2005-2009.
20. Norgren R.B., Mclean J.H., Bubel H.C., Wander A., Bernstein D.I., Lehman M.N. Anterograde transport of HSV-1 and HSV-2 in the visual system. Brain Res. Bull. 28:1992;393-399.
21. Ramsay A.J., Ruby J., Ramshaw I.A. A case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today. 14:1993;155-157.
22. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hygiene. 27:1938;493-497.
23. Ruby J., Ramshaw I. The antiviral activity of immune CD8+ T cells is dependent on interferon-gamma. Lymphokine Cytokine Res. 10:1991;353-358.
24. Schijns V., van Giersbergen P., Schellekens H., Horzinek M.C. Recombinant interferon-gamma applied to the brain ventricular system protects rats against pseudorabies. J. Neuroimmunol. 28:1990;1-7.
25. Schmid, D.S. and B.T. Rouse, 1992. The role of T cell immunity in control of herpes simplex virus. In: Rouse, B.T. (Ed.), Herpes simplex virus: Pathogenesis, immunobiology and control, Vol. 179, Springer-Verlag, Berlin, pp. 57-74.
26. Schmitt D.A., Sasaki H., Pollard R.B., Suzuki F. Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type-1. Antiviral Res. 19:1992;347-352.
27. Simmons, A., Tscharke, D., Speck, P., 1992. The role of immune mechanisms in control of herpes simplex virus infection of the peripheral nervous system. In: Rouse, B.T. (Ed.), Herpes simplex virus: Pathogenesis, immunobiology and control, Vol. 179, Springer-Verlag, Berlin, pp. 31-56.
28. Smith P.M., Wolcott R.M., Chervenak R., Jennings S.R. Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma). Virol. 202:1994;76-88.
29. Stanberry, L.R., 1992. Pathogenesis of herpes simplex virus infection and animal models for its study. In: Rouse, B.T. (Ed.), Herpes simplex virus: Pathogenesis, immunobiology and control, Vol. 179, Springer-Verlag, Berlin, pp. 15-30.
30. Svennerholm B., Ziegler R., Lycke E. Herpes simplex virus infection of the rat sensory neuron effects of interferon on cultured cells. Arch. Virol. 104:1989;153-156.
31. Wong G.H.W., Goeddel D.V. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons. Nature. 323:1986;819-822.
32. Wrzos H., Murasko D.M., Rapp F. Effect of antibody to interferon on genital herpesvirus infection in mice. Microb. Pathogenesis. 1:1986;71-78.
33. Yamada M., Arao Y., Hantano A., Uno F., Nii S. Effect of recombinant mouse interferon-beta on acute and latent herpes simplex infection in mice. Arch. Virol. 99:1988;101-109.